CREO.L vs. BRK-B
CREO.L (Creo Medical Group plc) and BRK-B (Berkshire Hathaway Inc.) are both stocks. CREO.L operates in Medical Devices (Healthcare), while BRK-B operates in Insurance - Diversified (Financial Services). Over the past 5 years, CREO.L returned -41.97%/yr vs 11.54%/yr for BRK-B. At a 0.01 correlation, their price movements are largely independent.
Performance
CREO.L vs. BRK-B - Performance Comparison
Loading charts...
Different Trading Currencies
CREO.L is traded in GBp, while BRK-B is traded in USD. To make them comparable, the BRK-B values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, CREO.L achieves a 38.89% return, which is significantly higher than BRK-B's -4.39% return.
CREO.L
- 1D
- 0.00%
- 1M
- 13.40%
- YTD
- 38.89%
- 6M
- 32.53%
- 1Y
- -14.06%
- 3Y*
- -17.23%
- 5Y*
- -41.97%
- 10Y*
- —
BRK-B
- 1D
- 0.00%
- 1M
- 3.19%
- YTD
- -4.39%
- 6M
- -5.72%
- 1Y
- -0.95%
- 3Y*
- 9.94%
- 5Y*
- 11.54%
- 10Y*
- 13.88%
CREO.L vs. BRK-B - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CREO.L Creo Medical Group plc | 38.89% | -49.23% | -57.61% | 82.18% | -83.05% | -23.20% | 7.18% | -9.05% | 186.33% | -14.72% |
BRK-B Berkshire Hathaway Inc. | -1.91% | 2.99% | 29.31% | 9.69% | 15.59% | 30.17% | -0.64% | 6.71% | 9.11% | 11.10% |
Correlation
The correlation between CREO.L and BRK-B is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.00 |
Correlation (All Time) Calculated using the full available price history since Dec 12, 2016 | 0.01 |
Fundamentals
CREO.L:
£56.76M
BRK-B:
$1.05T
CREO.L:
-£0.04
BRK-B:
$33.62
CREO.L:
1.57
BRK-B:
2.81
CREO.L:
1.14
BRK-B:
1.45
CREO.L:
£36.30M
BRK-B:
$375.39B
CREO.L:
£16.90M
BRK-B:
$94.36B
CREO.L:
-£40.80M
BRK-B:
$71.92B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CREO.L vs. BRK-B — Risk / Return Rank
CREO.L
BRK-B
CREO.L vs. BRK-B - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Creo Medical Group plc (CREO.L) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CREO.L | BRK-B | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.19 | ||
| Sortino ratioReturn per unit of downside risk | -0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.00 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | -0.34 | -0.08 | -0.26 |
| Martin ratioReturn relative to average drawdown | -0.53 | -0.17 | -0.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CREO.L | BRK-B | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.25 | -0.06 | -0.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.74 | 0.69 | -1.42 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.70 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.33 | 0.59 | -0.92 |
Drawdowns
CREO.L vs. BRK-B - Drawdown Comparison
The maximum CREO.L drawdown since its inception was -96.07%, which is greater than BRK-B's maximum drawdown of -37.92%. Use the drawdown chart below to compare losses from any high point for CREO.L and BRK-B.
Loading charts...
Drawdown Indicators
| CREO.L | BRK-B | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.07% | -37.92% | -58.15% |
Max Drawdown (1Y)Largest decline over 1 year | -41.41% | -11.88% | -29.53% |
Max Drawdown (3Y)Largest decline over 3 years | -80.15% | -17.26% | -62.89% |
Max Drawdown (5Y)Largest decline over 5 years | -95.66% | -20.84% | -74.82% |
Max Drawdown (10Y)Largest decline over 10 years | — | -21.44% | — |
Current DrawdownCurrent decline from peak | -94.34% | -13.90% | -80.44% |
Average DrawdownAverage peak-to-trough decline | -51.61% | -7.39% | -44.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.45% | 5.52% | +20.93% |
Volatility
CREO.L vs. BRK-B - Volatility Comparison
Creo Medical Group plc (CREO.L) has a higher volatility of 26.78% compared to Berkshire Hathaway Inc. (BRK-B) at 3.84%. This indicates that CREO.L's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CREO.L | BRK-B | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.78% | 3.84% | +22.94% |
Volatility (6M)Calculated over the trailing 6-month period | 46.42% | 11.84% | +34.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.05% | 15.33% | +40.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.96% | 16.89% | +40.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 50.77% | 19.85% | +30.92% |
Dividends
CREO.L vs. BRK-B - Dividend Comparison
Neither CREO.L nor BRK-B has paid dividends to shareholders.
Financials
CREO.L vs. BRK-B - Financials Comparison
This section allows you to compare key financial metrics between Creo Medical Group plc and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CREO.L and BRK-B have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CREO.L and BRK-B
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer